Long-term oral tetrahydrobiopterin supplementation reduces atherosclerosis in apolipoprotein E-KO mice

Ítems similars

• Long-term oral tetrahydrobiopterin supplementation reduces atherosclerosis in apolipoprotein e knockout mice
  per: Schmidt, T, et al.
  Publicat: (2008)
• Tetrahydrobiopterin supplementation reduces atherosclerosis and vascular inflammation in apolipoprotein E-knockout mice.
  per: Schmidt, T, et al.
  Publicat: (2010)
• Low-dose Tetrahydrobiopterin Supplementation Reduces Atherosclerosis Progression in Apolipoprotein E-Knockout Mice via Effects on Vascular T cell Infiltration
  per: Schmidt, T, et al.
  Publicat: (2009)
• Single dose oral tetrahydrobiopterin (BH4) leads to a prolonged increase in aortic BH4 levels in ApoE-KO mice
  per: Schmidt, T, et al.
  Publicat: (2007)
• Increased endothelial tetrahydrobiopterin synthesis reduces vein graft accelerated atherosclerosis in apolipoprotein E-knockout mice
  per: Ali, Z, et al.
  Publicat: (2006)